BMJ  2004;328:68 (10 January), doi:10.1136/bmj.328.7431.68-c

News

News roundup

New Zealand moves to ban direct advertising of drugs

Canberra

New Zealand's health minister, Annette King, will seek final approval from the cabinet later this month for the adoption of common standards with Australia on drug marketing, as a way of instituting a ban on advertising prescription only drugs directly to consumers.

New Zealand medical and consumer groups have cautiously welcomed the move as likely to result in the adoption of the Australian standard, which bans such advertising of prescription drugs but allows general campaigns raising awareness of disease.

After a pre-Christmas cabinet meeting, a brief press release by Ms King said that she had been authorised to "seek to reach agreement with Australia in March 2004" on a common standard on drug promotion (3 January, p 8). A spokesman for Ms King said final details on the plan would be put to the cabinet on 26 January.

The decision comes after the signing of a treaty in mid-December by the Australian and New Zealand governments to create a single agency regulating the registration and promotion of drugs, complementary health products, and medical devices.

In February 2003 a report by senior academic staff at all four of New Zealand's medical schools, "For Health or Profit?," proposed a ban on such advertising and the establishment of an independent advisory service for doctors and consumers. The report persuaded Ms King to review drug advertising standards.

New Zealand and the United States are the only developed countries that permit direct to consumer advertising for prescription drugs. A spokesman for Ms King was tight lipped on the prospect of a ban on such advertising, stating only that the cabinet would finalise the details later this month.

The chief body in New Zealand for the drugs industry, Researched Medicines Industry Association of New Zealand, declined to comment on the basis that the final decision had not been made. However, on its website the association argues that brand name advertising can "increase patient understanding and awareness of health problems, which can influence patients to seek early advice about treatment."

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Industry funded patient information and the slippery slope to New Zealand

Les Toop and Dee Mangin
BMJ 2007 335: 694-695. [Extract] [Full Text] [PDF]

Drug industry to fight New Zealand's move to ban direct to consumer advertising

Bob Burton
BMJ 2004 328: 1036. [Extract] [Full Text]

In brief
BMJ 2004 328: 8. [Extract] [Full Text] [PDF]